SCHEMBL20240233

SCHEMBL20240233

COC(=O)c1nc2c(cnn2C)c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.47
ALDH1A1 P00352 2/20 0.44
TP53 P04637 3/20 0.41
PDE5A O76074 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 1/20 0.39
TNKS O95271 3/20 0.39
TNKS2 Q9H2K2 3/20 0.39
HSD17B10 Q99714 2/20 0.39
ATM Q13315 1/20 0.38
TSHR P16473 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 1/20 0.38
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
ESR1 P03372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697070 0.85 PTGS2 (0.56) PTGS2ALDH1A1MEN1KMT2APOLB
SCHEMBL8198110 0.84 ALDH1A1 (0.47) PTGS2ALDH1A1TP53PDE5AMEN1
SCHEMBL20240237 0.82 ALDH1A1 (0.46) PTGS2ALDH1A1MEN1KMT2ATNKS
SCHEMBL8198106 0.76 PTGS2 (0.44) PTGS2ALDH1A1MEN1KMT2APOLB
SCHEMBL889723 0.73 CDK4 (0.55) ALDH1A1TNKS2HSD17B10CYP1A2CYP2C9
SCHEMBL14898534 0.73 ALDH1A1 (0.49) ALDH1A1PDE9APDE2A
SCHEMBL8114828 0.72 ALDH1A1 (0.51) ALDH1A1TP53MEN1KMT2ATNKS
SCHEMBL3424725 0.72 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ATNKSTNKS2
SCHEMBL889777 0.72 ALDH1A1 (0.56) ALDH1A1CYP1A2PDE2A
SCHEMBL23116100 0.71 CYP1A2 (0.43) ALDH1A1TP53CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3313852-B1 SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME (US) 2021-01-20 EP disclosed
EP-3313852-B1 SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME (US) 2021-01-20 EP disclosed
US-10647727-B2 Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors MERCK SHARP & DOHME CORP. (US) 2020-05-12 US disclosed
US-10647727-B2 Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors MERCK SHARP & DOHME CORP. (US) 2020-05-12 US disclosed
US-20180162874-A1 SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-14 US disclosed
US-20180162874-A1 SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-14 US disclosed
US-20180162874-A1 SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180162874-A1 SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS PDE2A, PDE12, PDE4D PTGS2 256/4885ALDH1A1 1148/4885TP53 4026/4885
US-10647727-B2 Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors PDE2A, PDE12, PDE4D PTGS2 256/4885ALDH1A1 1148/4885TP53 4026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.